🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

13 recruiting trials

for BRAF V600 Mutation

Detection of the BRAF V600E Mutation in Liquid Biopsy Using the CRISPR/Cas12a System NCT07870265NA1 site📍 Brno Masaryk Memorial Cancer Institute · Tests: Novel CRISPR/Cas12a Electrochemical Bioassay, Reference Standard Molecular Diagnostics (NGS and ddPCR), Serial Peripher… Dabrafenib and/or Trametinib Rollover Study NCT03340506Phase 438 sites📍 Scottsdale📍 Bethesda📍 Columbus Novartis Pharmaceuticals · Tests: dabrafenib, trametinib A Study on Treatment for Patients With BRAFV600E Mutant Metastatic Colorectal Cancer (mCRC) NCT06749015n/a1 site📍 Shanghai Fudan University · Tests: Non interventional study Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma NCT04903119Phase 14 sites📍 Iowa City📍 Lexington📍 Easton Rina Plattner · Tests: Nilotinib 100mg, Nilotinib 200mg, Nilotinib 300mg, Nilotinib 400mg, Dabrafenib Phase I Study of HSK42360-Na in Solid Tumors With BRAF V600 Mutation NCT07561554Phase 12 sites📍 Beijing📍 Beijing Haisco Pharmaceutical Group Co., Ltd. · Tests: HSK42360-Na Phase I Study of HSK42360 in Malignant Brain Tumors With BRAF V600 Mutation NCT07158710Phase 16 sites📍 Beijing📍 Beijing📍 Fuzhou Haisco Pharmaceutical Group Co., Ltd. · Tests: HSK42360 Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies NCT05786924Phase 1, Phase 249 sites📍 Gilbert📍 Los Angeles📍 Los Angeles Institut de Recherches Internationales Servier · Tests: S241656, FOLFOX6/FOLFOX7, FOLFIRI, Cetuximab, Panitumumab DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers. NCT07440290Phase 2, Phase 327 sites📍 Belfast📍 Birmingham📍 Birmingham Cancer Research UK · Tests: Dabrafenib, Trametinib Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas NCT07110246Phase 212 sites📍 Birmingham📍 San Francisco📍 Washington D.C. University of California, San Francisco · Tests: Dabrafenib, Trametinib, Magnetic Resonance Imaging (MRI), Specimen Collection, Optional Lumbar puncture Phase I Study of HSK42360 in Solid Tumors With BRAF V600 Mutation NCT06536400Phase 113 sites📍 Beijing📍 Beijing📍 Beijing Haisco Pharmaceutical Group Co., Ltd. · Tests: HSK42360 Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma NCT04741997EARLY Phase 11 site📍 Tampa H. Lee Moffitt Cancer Center and Research Institute · Tests: Encorafenib Pill, Binimetinib Pill, Nivolumab Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC NCT05800340Phase 21 site📍 Guanzhou Guangdong Provincial People's Hospital · Tests: Toripalimab, Nab paclitaxel, Pemetrexed, Carboplatin A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors NCT04913285Phase 148 sites📍 Los Angeles📍 Los Angeles📍 San Diego Pierre Fabre Medicament · Tests: KIN-2787, KIN-2787 and binimetinib
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy